Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1981 Nov;46(2):391–396.

Cytotoxicity of human peripheral blood monocytes against Trichomonas vaginalis.

A Mantovani, N Polentarutti, G Peri, G Martinotti, S Landolfo
PMCID: PMC1536403  PMID: 6279344

Abstract

Human peripheral blood monocytes were purified by adherence on microexudate-coated plastic and detached by exposure to 1 mM ethylenediamine tetracetic acid. Lysis of Trichomonas vaginalis was measured as release of 3H-thymidine from prelabelled protozoa after 48 hr of incubation. Human blood monocytes had appreciable levels of spontaneous cytotoxicity against Trichomonas vaginalis at effector-to-target cell ratios ranging from 3:1 to 25:1. Cytotoxicity was expressed with fetal bovine serum and human AB serum. Unseparated mononuclear cells, containing 10-25% monocytes as assessed by staining with non-specific esterase, were significantly cytotoxic against Trichomonas vaginalis but cytolysis levels were lower than those of purified monocytes. Lymphoid cells depleted of adherent cells by repeated incubations on plastic (less than 2% esterase-positive cells) had little cytotoxicity against these protozoa. In vitro exposure to silica natural 40-75% inhibition of the cytotoxic capacity of monocytic preparations. The natural cytotoxic capacity of human monocytes against Trichomonas vaginalis could represent one line of resistance against these protozoa.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Keller R. Macrophage-mediated natrual cytotoxicity against various target cells in vitro. I. Macrophages from diverse anatomical sites and different strains of rats and mice. Br J Cancer. 1978 May;37(5):732–741. doi: 10.1038/bjc.1978.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Landolfo S., Martinotti M. G., Martinetto P., Forni G. Natural cell-mediated cytotoxicity against Trichomonas vaginalis in the mouse. I. Tissue, strain, age distribution, and some characteristics of the effector cells. J Immunol. 1980 Feb;124(2):508–514. [PubMed] [Google Scholar]
  3. Mantovani A., Bar Shavit Z., Peri G., Polentarutti N., Bordignon C., Sessa C., Mangioni C. Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites. Clin Exp Immunol. 1980 Mar;39(3):776–784. [PMC free article] [PubMed] [Google Scholar]
  4. Mantovani A., Jerrells T. R., Dean J. H., Herberman R. B. Cytolytic and cytostatic activity on tumor cells of circulating human monocytes. Int J Cancer. 1979 Jan 15;23(1):18–27. doi: 10.1002/ijc.2910230105. [DOI] [PubMed] [Google Scholar]
  5. McLeod R., Bensch K. G., Smith S. M., Remington J. S. Effects of human peripheral blood monocytes, monocyte-derived macrophages, and spleen mononuclear phagocytes on Toxoplasma gondii. Cell Immunol. 1980 Sep 1;54(2):330–350. doi: 10.1016/0008-8749(80)90214-2. [DOI] [PubMed] [Google Scholar]
  6. Stutman O., Paige C. J., Figarella E. F. Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility. J Immunol. 1978 Nov;121(5):1819–1826. [PubMed] [Google Scholar]
  7. Tagliabue A., Mantovani A., Kilgallen M., Herberman R. B., McCoy J. L. Natural cytotoxicity of mouse monocytes and macrophages. J Immunol. 1979 Jun;122(6):2363–2370. [PubMed] [Google Scholar]
  8. Wilson C. B., Tsai V., Remington J. S. Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens. J Exp Med. 1980 Feb 1;151(2):328–346. doi: 10.1084/jem.151.2.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Zanella A., Mantovani A., Mariani M., Silvani C., Peri G., Tedesco F. A modified 'low pH' lignocaine method to isolate human monocytes: a comparison with other separation procedures. J Immunol Methods. 1981;41(3):279–288. doi: 10.1016/0022-1759(81)90191-5. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES